Background: It is ambiguous whether the multiple COS with supraphysiologic hormonal doses impact ovarian reserve functions or pregnancy outcomes. Furthermore, relevant retrospective studies are relatively scarce, chiefly in the last century, and ART techniques have seen innovation and improvement in the previous 20 years.
Methods: The retrospective study included 45,555 IVF/ICSI fresh cycles enrolled between January 2015 and March 2021 were segregated into 5 different cycle cohorts. The participants were retrospectively grouped according to the number of repeated cycles. The primary observables symbolizing ovarian reserve function were antral follicle count (AFC) and anti-Müllerian hormone (AMH). We analyzed clinical pregnancy rate (CPR), live birth rates (LBR), and early miscarriage rate (EMR) to explore clinical pregnancy outcomes. Statistical methods were used for intra-group self-control comparisons, between-group comparisons, and logistic regression analysis.
Result(s): Among the ovarian reserve function indicators, the AMH, AFC, basal FSH and basal LH exhibit no difference between groups (P> 0.05). In different populations, there was a natural dropout trend for CPR (r = - 0.922, P = 0.026) and LBR (r = - 0.920, P = 0.027) with increasing number of population repetitions, while EMR displayed an increasing trend (r = 0.957, P = 0.011). All differences between groups were statistically significant after logistic regression analysis. Intra-group analysis within same population revealed that, Cycle 2 in Group B (aOR = 8.29; 95% CI, 6.80-10.12; P = 0.000), Cycle 3 in Group C (aOR = 6.05; 95% CI, 3.28-11.15; P = 0.000) and Cycle 4 in Group D (aOR = 20.46; 95% CI, 3.05-137.24; P = 0.002) had the highest CPR within each group; Cycle 2 in Group B and Cycle 3 in Group C had the highest LBR and lowest EMR within each group, and the differences did not reached statistical significance in the remaining groups.
Conclusion(s): Repeated COS ( ≤ 5 times) does not disrupt ovarian reserve function. A raise in cycle number significantly increases CPR in the cohort of ≤ 4 repeated cycles, improves LBR, and reduces EMR in cohorts with ≤ 3 repeated cycles. Hence, patients are not advised to undergo ≥ 5 COS cycles.